Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3 study of Zuclomiphene Citrate for the treatment of moderate to severe hot flashes in men with advanced prostate cancer

Next Previous
X
Search
Trial Profile

A Phase 3 study of Zuclomiphene Citrate for the treatment of moderate to severe hot flashes in men with advanced prostate cancer

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 19 May 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Zuclomifene (Primary)
  • Indications Hot flashes
  • Focus Therapeutic Use

    • Most Recent Events

    • 19 May 2020 New trial record
    • 12 May 2020 According to an Veru Inc media release, following an End of Phase 2 meeting with the FDA, the company plans to advance Zuclomiphene Citrate to a Phase 3 clinical trial in men with advanced prostate cancer who experience moderate to severe hot flashes with a potential start date in late calendar year 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top